Skip to main content

Table 2 Univariate COX regression analyses of clinicopathologic factors associated with OS

From: Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma

Parameters

univariate analysis

HR(95% CI)

P value

T stage

2.845 (1.768–4.580)

< 0.001

New tumor events

5.222 (2.584–10.555)

< 0.001

Cancer status

2.460 (1.519–3.982)

< 0.001

BMI

0.680 (0.424–1.090)

0.109

Risk score

1.814 (1.123–2.930)

0.015

HCC risk factors

0.737 (0.437–1.243)

0.252

Surgical method

0.409 (0.251–0.667)

< 0.001

Residual tumor

1.415 (0.513–3.899)

0.502

Race

1.175 (0.726–1.903)

0.512

Grade

1.130 (0.670–1.825)

0.617

Gender

0.887 (0.538–1.462)

0.639

Other tumor

1.150 (0.496–2.668)

0.744

Age

0.933 (0.567–1.536)

0.785